Showing results (151-160 of 163) with videos related to
Sort By:
Pageof 17
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2014
Infections with the tick-borne bacterium "Candidatus Neoehrlichia mikurensis" mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseasesAnna Grankvist, Per-Ola Andersson, Mattias Mattsson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancerSören Lehmann, Vladimir J N Bykov, Dina Ali, et al.BMJ Open|September 15, 2021
COVID-19 in Pregnancy and Early Childhood (COPE): study protocol for a prospective, multicentre biobank, survey and database cohort studyYlva Carlsson, Lina Bergman, Mehreen Zaigham, et al.BMJ Open|June 30, 2026
Routine external aortic compression versus no aortic compression in elective caesarean delivery to reduce blood loss: study protocol of a randomised controlled trialHelena Grobecker, Mårten Alkmark, Ola Andersson, et al.Haematologica|March 6, 2025
Revaccination with pneumococcal conjugate vaccine five years after primary immunization improves immunity in patients with chronic lymphocytic leukemiaMagdalena Kättström, Bertil Uggla, Camilla Virta, et al.Haematologica|November 24, 2018
First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013Sandra Eketorp Sylvan, Anna Asklid, Hemming Johansson, et al.American Journal of Hematology|October 30, 2019
Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphomaMaysaa Abdulla, Peter Hollander, Tatjana Pandzic, et al.Plos One|August 29, 2009
Selective and irreversible inhibitors of mosquito acetylcholinesterases for controlling malaria and other mosquito-borne diseasesYuan-Ping Pang, Fredrik Ekström, Gregory A Polsinelli, et al.Leukemia & Lymphoma|January 20, 2016
Phase III, randomized study of ofatumumab versus physicians' choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemiaAnders Österborg, Miklós Udvardy, Andrey Zaritskey, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 5, 2025
The association between antenatal SARS-CoV-2 exposure and infant neurodevelopment at four months of age: A prospective multicenter cohort survey within the COPE studyJohan Berg, Karolina Linden, Mehreen Zaigham, et al.Pageof 17